Hideki Kawanishi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Peritoneal Dialysis

Infectious Diseases

Recombinant Human

Top Venues

Journal of clinical medicine

Clinical journal of the American Society of Nephrology : CJASN

This page only lists publications with an associated author ORCID identifier.

Publications

Hideki Kawanishi
Middle Molecular Uremic Toxin and Blood Purification Therapy. Journal of clinical medicine 13 (3) (2024)
Hideki Kawanishi
Middle Molecular Uremic Toxin and Blood Purification Therapy. Journal of clinical medicine 13 (3) (2024)
Mark Lambie, Junhui Zhao, Keith McCullough, Simon J Davies, Hideki Kawanishi, David Wayne Johnson, James A Sloand, Mauricio Sanabria, Talerngsak Knananjubach, Yong-Lim Kim, Jenny I Shen, Ronald L Pisoni, Bruce M Robinson, Jeffrey Perl, null null
Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study. Clinical journal of the American Society of Nephrology : CJASN 17 (6) (2022)
Simon J Davies, Junhui Zhao, Keith P McCullough, Yong-Lim Kim, Angela Yee-Moon Wang, Sunil V Badve, Rajnish Mehrotra, Talerngsak Knananjubach, Hideki Kawanishi, Bruce Robinson, Ronald Pisoni, Jeffrey Perl, null null
International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival. Kidney360 3 (5) (2022)
Tomoyuki Takura, Makoto Hiramatsu, Hidetomo Nakamoto, Takahiro Kuragano, Jun Minakuchi, Hironori Ishida, Masaaki Nakayama, Susumu Takahashi, Hideki Kawanishi
Health economic evaluation of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study. ClinicoEconomics and outcomes research : CEOR 11 (2019)
Masataka Banshodani, Hideki Kawanishi, Shingo Fukuma, Misaki Moriishi, Sadanori Shintaku, Shinichiro Tsuchiya
The impact of hemodialysis schedules on the day of the week of hospitalization for cardiovascular and infectious diseases, over a period of 20 years. PloS one 12 (7) (2017)